Beclometasone vs placebo
It is very uncertain whether beclometasone changes mortality (all‐cause) (dichotomous Peto method) compared with placebo (very low certainty).
- OR 0.94 [0.26, 3.34]1 study · 194 participantsVery low
It is very uncertain whether beclometasone changes mortality (all‐cause) (dichotomous Peto method) compared with placebo (very low certainty).
It is very uncertain whether beclometasone/LABA changes mortality (all‐cause) (dichotomous Peto method) compared with LABA (very low certainty).
The review found no eligible studies for this question.
Cerebral NIRS oximetry showed no clear difference in all‐cause mortality compared with no cerebral NIRS oximetry (low certainty).
Summary of Findings Table ‐ Electrocoagulation in combination with… may leads to lower all‐cause mortality at last compared with control (vehicle solution of allopurinol by mouth) (low certainty).
Metoprolol showed no clear difference in all‐cause mortality, 30 days1 compared with placebo (low certainty).
Metoprolol showed no clear difference in all‐cause mortality, 6 months1 compared with placebo (low certainty).
It is very uncertain whether thrombopoietin mimetic changes all‐cause mortality compared with placebo (very low certainty).
Metoprolol showed no clear difference in all‐cause mortality compared with placebo or no treatment (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether summary of findings of metformin monotherapy for adults with type 2… changes all‐cause mortality compared with thiazolidinediones (very low certainty).
The review found no eligible studies for this question.
Adults: formoterol/ICS showed no clear difference in all‐cause mortality ‐ formoterol/budesonide vs salmeterol/fluticasone compared with salmeterol/ICS (low certainty).
Adults: formoterol/ICS showed no clear difference in all‐cause mortality ‐ formoterol/mometasone vs salmeterol/fluticasone compared with salmeterol/ICS (low certainty).
Adults: formoterol/ICS showed no clear difference in all‐cause mortality ‐ formoterol/fluticasone vs salmeterol/fluticasone compared with salmeterol/ICS (low certainty).